Allt inom Q2

Nanexa publishes interim report for January – June 2022

The pilot plant inaugurated and GMP certified, patent approved in Europe and product projects approaching clinical phase

Nanexa publishes interim report for January – June 2021

First clinical study started and long-term financing secured